Bring the power of NGS to your lab with easy-to-use platforms
Benchtop sequencers give users the power of next-generation sequencing (NGS) in a flexible and accessible design. Built with operational simplicity including preconfigured analysis workflows, these systems enable novice and experienced NGS users to bring NGS in-house and perform targeted sequencing across a range of applications.
A benchtop sequencer can provide a cost-efficient solution for low and mid-throughput applications and for library quality control (QC) prior to large-scale studies.
For users that are outsourcing their sequencing projects, investing in a benchtop sequencer to bring NGS in-house can offer several advantages:
Depending on your needs, benchtop sequencers feature low- or mid-throughput configurations to support a broad range of applications while delivering exceptional data quality and accuracy.
Output: 15 megabases (Mb) to 50 gigabases (Gb)
Reads per run: 1 million to 40 million
Output: 10 Gb to 540 Gb
Reads per run: 75 million to 1.8 billion
Benchtop sequencers support a broad range of applications and throughputs. Explore a step-by-step guide to aid you in choosing which NGS system best meets the needs of your lab.
Key factors to consider when looking to purchase a benchtop sequencing system include what applications your lab will use most and how you will analyze the data you generate.
Your methods and applications help determine if you need a low- or mid-throughput benchtop sequencer. If you’re primarily interested in small whole-genome, microbial metagenomics, and targeted gene sequencing, a low-throughput benchtop sequencer would be a good fit. For methods like whole-exome and single-cell, consider a mid-throughput benchtop sequencer.
Your goals for analysis are an important consideration when choosing a sequencing platform. Novice users may benefit from user-friendly, preconfigured analysis pipelines available on-instrument or in the cloud. For experienced users, you can take advantage of instrument compatibility with broader informatics pipelines or build your own.
Whether your lab is acquiring its first NGS sequencer, or is ready to scale up, Illumina offers proven benchtop sequencers with simplified operation, flexible and scalable sequencing, and intuitive data analysis. Straightforward, thoughtful design that includes onboard cluster generation and minimal maintenance sets these sequencers apart.
The MiSeq System has a simplified NGS workflow making it easy for novice users to access NGS, quickly and reliably. With more than 10,000 systems shipped globally, the MiSeq System has the largest benchtop system install base on the market. Cited in over 100,000 peer-reviewed publications,1 it has been trusted for over a decade.
The NextSeq 1000 and NextSeq 2000 Sequencing Systems are flexible and scalable, empowering scientists to explore applications like single cell, whole-exome, and RNA sequencing. With more than 2150 systems shipped globally, they feature simplified run setup, minimal touchpoints, and flexible informatics solutions, including onboard DRAGEN software.
Get up and running quickly with an instrument or reagent rental or leasing program designed to work with your budget. Explore benchtop sequencer purchasing and trade-in solutions to meet your business needs.
When determining the best benchtop sequencer for your lab, it is important to select a vendor with a record of excellence. At Illumina, we continue our pursuit of innovation to inspire scientists to join our growing genomics community, and our proven performance has contributed to Illumina being cited more than any other sequencing company.
In these videos and articles, hear from others about their experience with Illumina benchtop sequencing systems.
In this video, learn about the robustness of the NextSeq 2000 System and how it was able to support Dr Tomas Szemes’ team from Comenius University Science Park, in Slovakia, to double their previous sequencing efforts.
Hear from researchers who have used the NextSeq 1000 and NextSeq 2000 Systems for genomic surveillance, CRISPR screening, single-cell RNA Seq, and more, in this introductory video.
In this article, Dr Philip Supply explains how he uses the MiSeq System to evaluate patterns of extensive resistance, transmission, and evolution to identify multidrug-resistant tuberculosis strains responsible for silent outbreaks.
Reach out for information about our products and services, or get answers to questions about our technology.
Your email address is never shared with third parties.
References
